))
The Shortage of Stimulant Medications for ADHD - Why It's Still a Problem Today
Manage episode 435415553 series 3588182
Contenido proporcionado por Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In this episode, we take a quick break from attachment theory and dive into a very real, current problem we face today: the stimulant medication shortage for the treatment of ADHD. We explore the complex regulatory systems surrounding stimulants, including supply chain issues and being lumped into the category of Schedule II medications monitored by the Drug Enforcement Agency (DEA) to fight the Opioid Epidemic. The pressures from many layers of control fall on the shoulders of the pharmacist, and worst of all, the patients. Lastly, we discuss how to mitigate this shortage issue for patients, and the need for patient advocacy amongst clinicians.
Have questions for us, or feedback about our podcast? Send us a message!
8 episodios
Compartir
